Insider Selling: BKV (NYSE:BKV) SVP Sells $318,460.21 in Stock

BKV Corporation (NYSE:BKV) SVP Javier Hinojosa sold 12,377 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $25.73, for a total value of $318,460.21. Following the sale, the senior vice president directly owned 84,276 shares of the company’s stock, valued at approximately $2,168,421.48. This represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

BKV Trading Up 0.2%

NYSE BKV opened at $24.24 on Monday. The business’s fifty day moving average is $25.54 and its 200-day moving average is $27.61. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.15 and a quick ratio of 1.10. The stock has a market capitalization of $2.65 billion, a price-to-earnings ratio of 8.85 and a beta of 1.09. BKV Corporation has a one year low of $20.08 and a one year high of $32.81.

BKV (NYSE:BKV) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.21. BKV had a net margin of 17.73% and a return on equity of 6.67%. The company had revenue of $465.54 million during the quarter, compared to analyst estimates of $355.25 million. Equities research analysts predict that BKV Corporation will post 1.77 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Weiss Ratings lowered shares of BKV from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, May 27th. Jefferies Financial Group reissued a “buy” rating and issued a $34.00 target price on shares of BKV in a research report on Friday, July 10th. Truist Financial lowered their target price on BKV from $34.00 to $33.00 and set a “buy” rating on the stock in a research note on Monday, August 10th. Wall Street Zen raised BKV from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Finally, Zacks Research upgraded BKV from a “strong sell” rating to a “hold” rating in a research note on Monday, June 15th. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $34.25.

Institutional Trading of BKV

A number of institutional investors have recently modified their holdings of the business. Moore Capital Management LP bought a new position in BKV in the 2nd quarter worth approximately $2,001,000. IMC Chicago LLC purchased a new stake in shares of BKV during the second quarter worth $662,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of BKV by 37.1% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 30,084 shares of the company’s stock worth $823,000 after acquiring an additional 8,144 shares in the last quarter. Empowered Funds LLC bought a new position in shares of BKV in the second quarter worth $1,361,000. Finally, Value Aligned Research Advisors LLC boosted its holdings in shares of BKV by 110.5% in the second quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company’s stock worth $18,602,000 after acquiring an additional 356,848 shares during the period.

BKV Company Profile

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas. BKV Corporation, LLC operates as a subsidiary of Banpu North America Corporation.